
1. clin appl thromb hemost. 2019 jan-dec;25:1076029618821184. doi:
10.1177/1076029618821184.

zika chikungunya virus risk venous thromboembolism.

ramacciotti e(1), agati lb(1), aguiar vcr(1), wolosker n(2), guerra jc(2), de
almeida rp(3), alves jc(3), lopes rd(4), wakefield tw(5), comerota aj(6), walenga
j(7), fareed j(7).

author information: 
(1)1 hospital e maternidade dr. christovão da gama, santo andré, são paulo,
brazil.
(2)2 hospital israelita albert einstein, são paulo, sp, brazil.
(3)3 universidade federal de sergipe, aracajú, se, brazil.
(4)4 duke university hospital, duke clinical, durham, nc, usa.
(5)5 michigan medicine, cardiovascular center, university michigan, ann arbor,
mi, usa.
(6)6 mercy st. vincent medical center, toledo, oh, usa.
(7)7 loyola university medical center, maywood, il, usa.

a variety viral infections associated hypercoagulable states may 
be linked development deep venous thrombosis pulmonary embolism.
the zika chikungunya viral infections spread south central
american continents, moving north america 2016, severe cases of
polyarthralgia, fever, guillain-barré syndrome leading eventually death. a
decreased trend infections reported first quarter 2017. in
this article, report possible association venous thromboembolic events 
associated zika infection. 2 cases deep venous thrombosis in
patients acute zika infections, d-dimer levels measured 172
consecutive patients presented emergency department university
hospital endemic region brazil either zika chikungunya
infections confirmed polymerase chain reaction tests. d-dimer levels were
increased 19.4% 31 patients zika 63.8% 141 patients with
chikungunya infections. mechanisms behind association yet be
elucidated well potential venous thromboembolism prevention
strategies in-hospital patients affected zika chikungunya infections.

doi: 10.1177/1076029618821184 
pmcid: pmc6714924
pmid: 30808213  [indexed medline]

